Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Norgestrel

A synthetic progestin used in the contraceptive pill, synthesised in the early 1960s by chemist Herchel Smith and colleagues and launched in 1966 in Germany, combined with ethinylestradiol. This family brings together the active ingredient, pharmacopoeial impurities and metabolites.

Did you know?It is a mixture of two mirror-image forms and only one, levonorgestrel, is active. In 2023 it became the first daily contraceptive pill approved for sale without a prescription in the United States.

NorgestrelGo to the active ingredient →
NorgestrelActive ingredientNorgestrelCat. No. P-N094-001CAS 6533-00-2

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceNorgestrel CRSEDQM code N1250000Family Norgestrel

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.